While paramacular retinal atrophy (PRA) is known to be found in 48% of eyes of adults and 42% of eyes of children with homozygous SCD (SS-SCD), the aim of this study is to assess the association between PRA and red blood cell (RBC) deformability, hematological markers and brain imaging abnormalities in SS-SCD.
Methods
This study is a subset of DREAM2, a prospective observational study performed between August 2015 and August 2016. Children (5–17 years) with SS-SCD and no history of large vessel vasculopathy, were included. Ophthalmological characteristics including visual acuity, fundus examination, OCT of central and temporal retina (with several retinal thickness measurements) were explored in relation with RBC deformability (ektacytometry), hematological and biochemical (hemolysis parameters), and neurological (cerebral oxygenation estimated by Near Infrared Spectroscopy, brain magnetic resonance imaging) investigations.
Results
17 children (5 boys; mean age: 13 years) with complete ophthalmological investigations were included in the analysis; 8 exhibited PRA. RBC deformability was found to be significantly lower in children with PRA for measurements made at 1.69 Pa (0.16 a.u ± 0.02 vs 0.21 a.u ± 0.03, p = 0.02) and above, as well as cerebral oxygenation (59.25% ± 9.9 vs 71.53% ± 4.9, p = 0.02). A significant positive correlation was found between temporal retinal thickness and hemoglobin level (ρ = 0.65, p = 0.007), hematocrit (ρ = 0.53, p = 0.04) and RBC deformability at 3 Pa (ρ = 0.75, p = 0.005) and above.
Conclusions
These results suggest that PRA could be an early marker of systemic severity and cerebral oxygenation in SCD. Whether it could help predicting cerebral vasculopathy requires further investigations.
ElagouzMJyothiSGuptaB,et al.Sickle cell disease and the eye: old and new concepts. Surv Ophthalmol. Juill2010; 55: 359–377.
2.
LiJBenderLShafferJ,et al.Prevalence and onset of pediatric sickle cell retinopathy. Ophthalmology. juill 2019; 126: 1000–1006.
3.
MyintKTSahooSTheinAW,et al.Laser therapy for retinopathy in sickle cell disease. Cochrane Database Syst Rev9 oct 2015; 10: CD010790.
4.
HabibiAArletJ-BStankovicK, et al.Recommandations françaises de prise en charge de la drépanocytose de l’adulte : actualisation 2015. Rev Médecine Interne. mai2015; 36: 5S3–584.
5.
MurthyRK. Temporal macular thinning on spectral-domain optical coherence tomography in proliferative sickle cell retinopathy. Arch Ophthalmol1 févr 2011; 129: 247.
6.
BachmeierIBlechaCFöllJ,et al.Maculopathy in sickle cell disease. Ophthalmologe2021.118(10): 1013–1023. DOI: 10.1007/s00347-020-01319-8.
7.
GoldbaumMH. Retinal depression sign indicating a small retinal infarct. Am J Ophthalmol. Juill1978; 86: 45–55.
8.
WitkinAJ. Optical coherence tomography demonstration of macular infarction in sickle cell retinopathy. Arch Ophthalmol1 mai 2006; 124: 746.
9.
MathewRBafiqRRamuJ, et al.Spectral domain optical coherence tomography in patients with sickle cell disease. Br J Ophthalmol. Juill2015; 99: 967–972.
10.
MartinGCAlbuissonEBrousseV,et al.Paramacular temporal atrophy in sickle cell disease occurs early in childhood. Br J Ophthalmoljuill 2019; 103: 906–910.
11.
MartinGCDénierCZambrowskiO, et al.Visual function in asymptomatic patients with homozygous sickle cell disease and temporal macular atrophy. JAMA Ophthalmol1 oct 2017; 135: 1100.
12.
MinvielleWCaillauxVCohenSY, et al.Macular microangiopathy in sickle cell disease using optical coherence tomography angiography. Am J Ophthalmol. avr2016; 164: 137–144.e1.
13.
HanICTadaratiMPachecoKD,et al.Evaluation of macular vascular abnormalities identified by optical coherence tomography angiography in sickle cell disease. Am J Ophthalmol. mai2017; 177: 90–99.
RobertMPIngster-MoatiIRocheO, et al.Asymptomatic atrophy of the temporal median raphe of the retina associated with cerebral vasculopathy in homozygous sickle cell disease. J Am Assoc Pediatr Ophthalmol Strabismus. Août2012; 16: 394–397.
16.
OngSSLinzMOLiX,et al.Retinal thickness and microvascular changes in children with sickle cell disease evaluated by optical coherence tomography (OCT) and OCT angiography. Am J Ophthalmol. Janv2020; 209: 88–98.
17.
Dell’ArtiLBarteselliGRivaL, et al.Sickle cell maculopathy: identification of systemic risk factors, and microstructural analysis of individual retinal layers of the macula. Lewin AS, éditeur. PLOS ONE1 mars 2018; 13: e0193582.
18.
BeralLLemonneNRomanaM, et al.Proliferative retinopathy and maculopathy are two independent conditions in sickle cell disease: is there a role of blood rheology?1. Clin Hemorheol Microcirc28 mai 2019; 71: 337–345.
19.
BrousseVPondarreCKossorotoffM, et al.Brain injury pathophysiology study by a multimodal approach in children with sickle cell anemia with no intra or extra cranial arteriopathy. Haematologica. 2021. DOI: 10.3324/haematol.2020.278226. Online ahead of print.
20.
FordALRaganDKFellahS, et al.Silent infarcts in sickle cell disease occur in the border zone region and are associated with low cerebral blood flow. Blood18 oct 2018; 132: 1714–1723.
21.
BaskurtOKBoynardMCokeletGC, et al.New guidelines for hemorheological laboratory techniques. Clin Hemorheol Microcirc2009; 42: 75–97.
22.
AdamsRJMcKieVCHsuL, et al.Prevention of a first stroke by transfusions in children with sickle cell anemia and abnormal results on transcranial Doppler ultrasonography. N Engl J Med2 juill 1998; 339: 5–11.
23.
HulbertMLMcKinstryRCLaceyJL, et al.Silent cerebral infarcts occur despite regular blood transfusion therapy after first strokes in children with sickle cell disease. Blood20 janv 2011; 117: 772–779.
24.
PerreyS. Non-invasive NIR spectroscopy of human brain function during exercise. Methods. Août2008; 45: 289–299.
25.
NahavandiMNicholsJPHassanM,et al.Near-infrared spectra absorbance of blood from sickle cell patients and normal individuals. Hematology. Févr2009; 14: 46–48.
26.
ConnesPAlexyTDetterichJ,et al.The role of blood rheology in sickle cell disease. Blood Rev. Mars2016; 30: 111–118.
27.
LimWSMaganTMahrooOA,et al.Retinal thickness measurements in sickle cell patients with HbSS and HbSC genotype. Can J Ophthalmolaoût 2018; 53: 420–424.
28.
LimJICaoD. Analysis of retinal thinning using spectral-domain optical coherence tomography imaging of sickle cell retinopathy eyes compared to age- and race-matched control eyes. Am J Ophthalmolaoût 2018; 192: 229–238.
29.
WangMHussnainSAChenRWS. The role of retinal imaging in sickle cell retinopathy: a review. Int Ophthalmol Clin2019; 59(1): 71–82. DOI: 10.1097/IIO.0000000000000255.
30.
HussnainSACoadyPASladeMD, et al.Hemoglobin level and macular thinning in sickle cell disease. Clin Ophthalmolavr 2019; 13: 627–632.
31.
GregoLPignattoSAlfierF, et al.Optical coherence tomography (OCT) and OCT angiography allow early identification of sickle cell maculopathy in children and correlate it with systemic risk factors. Graefes Arch Clin Exp Ophthalmol Albrecht Von Graefes Arch Klin Exp Ophthalmol.nov 2020; 258: 2551–2561.
32.
FaresSHajjarSRomanaM, et al.Sickle cell maculopathy: microstructural analysis using OCTA and identification of genetic, systemic, and biological risk factors. Am J Ophthalmol4 janv 2021; 224: 7–17.
33.
RoyMSGasconPGiulianiD. Macular blood flow velocity in sickle cell disease: relation to red cell density. Br J Ophthalmol1 août 1995; 79: 742–745.
34.
Ohene-FrempongKWeinerSJSleeperLA, et al.Cerebrovascular accidents in sickle cell disease: rates and risk factors. Blood1 janv 1998; 91: 288–294.
35.
BernaudinFVerlhacSFréardF, et al.Multicenter prospective study of children with sickle cell disease: radiographic and psychometric correlation. J Child Neurolmai 2000; 15: 333–343.
36.
BernaudinFVerlhacSArnaudC, et al.Chronic and acute anemia and extracranial internal carotid stenosis are risk factors for silent cerebral infarcts in sickle cell anemia. Blood5 mars 2015; 125: 1653–1661.
37.
DeBaunMRJordanLCKingAA, et al.American Society of hematology 2020 guidelines for sickle cell disease: prevention, diagnosis, and treatment of cerebrovascular disease in children and adults. Blood Adv28 avr 2020; 4: 1554–1588.
38.
BernaudinFVerlhacSArnaudC, et al.Impact of early transcranial Doppler screening and intensive therapy on cerebral vasculopathy outcome in a newborn sickle cell anemia cohort. Blood27 janv 2011; 117: 1130–1140.
